01 January 2005
Effect of lower-body negative pressure on cerebral blood fl ow velocity during 21 days head-down tilt bed rest
Xi-Qing Sun, Yong-Jie Yao, Chang-Bin Yang, Shi-Zhong Jiang, Chang-Lin Jiang, Wen-Bin LiangMed Sci Monit 2005; 11(1): CR1-5 :: ID: 13868
Abstract
Background: The purpose of this study was to investigate cerebral blood fl ow (CBF) velocity in humans during 21 days of head-down tilt (HDT) bed rest with and without lower-body negative pressure (LBNP). Material/Methods: Twelve healthy male volunteers were exposed to –6° HDT bed rest for 21 days. Six subjects received –30 mmHg LBNP sessions for 1 h per day from the 1[sup]st[/sup] to the 7[sup]th[/sup] day and from the 15[sup]th[/sup] to the 21st day of HDT, and six others served as controls. CBF velocity was measured by use of the transcranial Doppler technique in the right middle cerebral artery before and during HDT. Results: In the control group, mean and systolic CBF velocities decreased on day 1 of HDT compared with the pre-HDT value, and dropped further on day 3 of HDT, then remained signifi cantly below the pre-HDT baseline on days 7 and 10 of HDT, and reached a minimum value on day 21 of HDT. In the LBNP group, mean and systolic CBF velocities decreased signifi cantly on day 1 of HDT compared with the pre-HDT value, and remained lowered throughout HDT. Diastolic CBF showed no signifi cant change throughout HDT in both groups. There were no signifi cant differences in these parameters between the two groups. Conclusions: The results of this study suggest that CBF velocity is reduced during 21 days of HDT, and brief daily LBNP sessions used in the fi rst and last weeks of 21-day HDT bed rest does not improve CBF velocity.
Keywords: Head-Down Tilt - adverse effects, Bed Rest, Blood Pressure, Cerebrovascular Circulation, Head-Down Tilt - adverse effects, Lower Body Negative Pressure, Ultrasonography, Doppler, Transcranial, Weightlessness
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952